Answers are grounded in this paper and cite their sources.
The high incidence of NKX2-1 mutations strongly recommends the routine screen for mutations in patients with corresponding symptoms. However, this analysis should not be confined to the exonic sequence alone, but should take advantage of affordable NGS technology to expand the target to adjacent regulatory sequences and the NKX2-1 interactome in order to maximise the yield of this diagnostic effort.
No takes yet. Share an insight, caveat, or question.
Thorwarth et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: